Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02234986
Title A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CASI Pharmaceuticals, Inc.

fibrolamellar carcinoma



Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
CASI Site 03 San Francisco California 94158 United States Details
CASI Site 04 Aurora Colorado 80045 United States Details
CASI Site 02 Boston Massachusetts 01003 United States Details
Casi Site 01 New York New York 10065 United States Details
CASI Site 05 Dallas Texas 75231 United States Details
*Shaded cells indicate that there was no data available from for the field